Objectives: Neopterin is a valuable diagnostic biomarker, which is elevated in inflammatory conditions like periodontitis, that is characterized by destruction of the supporting structures of the teeth. Among the biomarkers, neopterin occurs in body fluids, and acts as a diagnostic marker for present and future disease activity. Methods: Thirty female subjects with chronic periodontitis, mean age 50 years (40-60 years) were included in this study. Depending upon their menstrual history, subjects were categorized into two groups of fifteen each. Group I 15 pre-menopausal women, and Group II 15 post-menopausal women. Saliva was collected, and neopterin levels were assessed by enzyme-linked immunosorbent assay in both the groups, at base line and after three months of nonsurgical periodontal therapy (NSPT). Periodontal parameters like pocket probing depth (PD) and Russell's periodontal disease index (PDI) were assessed before treatment as well as after three months of scaling and root planning. Results: Intra group analysis showed significant markdown in the mean values of all the parameters from baseline to three months (P < 0.001), for all patients. The intergroup comparison, from baseline to 3 months also showed no significant change in PD and PDI values, but there was a statistically significant difference in the salivary neopterin levels (P = 0.04). Conclusions: Neopterin levels were found to be reduced in three months after NSPT in both the groups, suggesting that the NSPT is the gold standard therapy, and also that neopterin levels in saliva can be used as an indicator to identify periodontal inflammation and destruction. (J Menopausal Med 2017;23:32-41)
Introduction
Periodontitis is an inflammatory disease that destroys both soft and hard tissues around the tooth. Recent trends in diagnostic research, includes measuring biomarkers, whereby prior risk to periodontitis will be identified.
Circulating elevated levels of specific inflammatory markers can be correlated with the severity of the periodontal disease activity. 1 The diagnosis of progressive phases of periodontal disease and classifying of patients who are at risk represents a major challenge for both investigators and clinicians. This identification can be accomplished by using biomarkers that are expressed in body fluids like gingival crevicular fluid (GCF), saliva and serum. 2 A biomarker is the biologic measure that can be used
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Jammula Surya Prasanna 1 , Chinta Sumadhura 1 , Parupalli Karunakar 2 , Naineni Rohini as an index. It may be computed and evaluated as an indicator of normal, pathogenic biological processes or pharmacological responses to a therapeutic intervention. 3 A traditional biomarker for periodontal disease is bleeding on probing (BOP), and is a reliable predictor available today.
Researchers report that there are many false positive assumptions associated with it, but the absence of BOP is considered a very precise negative predictor of disease activity. 3 Despite chronic periodontitis (CP) being a site specific disease, its susceptibility to a patient and site level is still unclear. Thereby, wide research activities were commenced since 1990 to evaluate the importance and correlation of individual biomarkers of periodontal disease activities, measured within GCF. 4 Neopterin is an early and a valuable biomarker of cellular immunity, shown to be a sensitive assessment parameter for cell-mediated immune reactions. Hence determination of neopterin concentrations in distinctive body fluids is of diagnostic interest in a wide range of T lymphocytes and macrophages originated diseases. Increased neopterin production is also found in infections due to intracellular living bacteria and parasites. 5, 6 Neopterin concentration is directly proportional to the reactive oxygen species levels and is inversely related to the serum concentration of antioxidants like alpha-tocopherol.
Hence it can be regarded as a marker of reactive oxygen species formed by the activated cellular immune system. 7 The present study was undertaken to determine salivary neopterin levels in patients with periodontitis in pre-and post-menopausal women. We also aimed to evaluate the usefulness of neopterin as a biomarker to correlate the intensity of periodontal tissue destruction and its reverting response to nonsurgical periodontal therapy (NSPT). 
Materials and Methods

1) Sensitivity
By determining the resulting concentration of the mean optical density (OD) of Calibrator A (based on 10 replicate analyses) minus 2 standard deviation (SD), lower detection limit is calculated from the SC.
Therefore, the sensitivity of the neopterin ELISA kit is 0.7 nmol/L.
2) Specificity (cross reactivity)
The cross-reactivity was tested for these compounds with the direct neopterin ELISA kit with neopterin cross- Values that bind either higher or lower than the SC should not be determined by extrapolation.
Statistical analysis
The observations recorded were subjected to statistical analysis using IBM SPSS version 21 software (SPSS Inc., Chicago, IL, USA). The average of the clinical variables (PD, PDI for both the groups), the amount of saliva, and the amount of neopterin were calculated for each subject in both the groups and this mean value is used as the response variable. Results were symbolized as mean ± SD. were examined using the Independent sample t test .The correlation between the levels of neopterin and clinical variables of the two groups were analyzed separately using paired t-test. P value < 0.05 was considered statistically significant.
Results
Intra group comparison showed statistically significant reduction in the mean values of all the parameters from baseline to three months within the group I and II (Table 1) .
In group I, the mean salivary neopterin levels were reduced from 13.63 ± 1.55 at baseline to 6.69 ± 1.24 in 3 months after treatment. The mean periodontal index levels have reduced from 6.08 ± 0.47 at baseline to 2.54 ± 0.12 in 3 months after treatment. In group II, the mean salivary neopterin levels were reduced from 15.61 ± 1.83 at baseline When we compare these values in both groups from baseline to 3 months, a statistically significant difference in the salivary neopterin levels (P = 0.04) were observed ( Table   3 , Fig. 3 ). cytokine that induces the production of large amounts of neopterin in cell culture supernatants. On the other hand in human monocytes/macrophages and in some cell lines stimulated with this cytokine, neopterin is produced and released instead of other pteridine derivatives. 15, 16 Periodontitis is a very common chronic infection or inflammation of the tissue surrounding the teeth. Severe attachment loss and bone loss progresses if untreated.
Discussion
However the nature and source of inflammation is unclear, but many studies have proven that periodontal therapy resolves the periodontal as well as systemic inflammation.
17~19
Recent studies demonstrated that, traditional clinical measures of human periodontal diseases are not designating of ongoing the future disease progression. 20 Determination of the presence of inflammatory products found in GCF or saliva may be of value in evaluating both periodontal disease status and the outcome of therapy. 21 Evaluation of neopterin status in various human biological fluids was done by many authors. 22~24 Exclusive studies on saliva, GCF as a biomarker 
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of neopterin was also done by many authors. 23, 24 Menopause accomplishes a wide range of changes in women' s body, and the oral cavity is also not exceptional.
As exalted levels of ovarian hormones, detected in pregnancy and oral contraceptive usage, can lead to an increase of gingival inflammation. On contrary, menopause shows depleted levels of ovarian sex steroids, which also causes worsening of gingival health. 25 As far as gingiva is concerned, the effect of sex hormones is that they can Estrogen may induce an overall inhibitory effect on inflammation by suppressing pro inflammatory pathways.
Bouman et al. 27 and Bolego et al. 28 found an enhanced inflammatory potential when macrophages individuate from the peripheral blood of the post-menopausal women were compared to those women of fertile age. Signaling reciprocal action is responsible by estrogen for the onset of the resolution phase and is able to shorten the perpetuation of the pro-inflammatory contingency and to direct the resolution of the inflammation towards the acquired deactivation stage. These findings may be conformant particularly for the identification of novel ER modulators efficacious in the prevention or mitigation of chronic inflammation. 29 Reinforcing this affirmation many authors proved that alternative immune action of macrophages is reduced by estrogen treatment in menopause. 30 Although few studies about neopterin activity in saliva were discussed, 22, 23 but possible association with menopause and periodontitis salivary neopterin was not discussed earlier. As per our knowledge, this is the first study which correlated these three inflammatory conditions. In the present study, it was determined that the mean total amount of neopterin values of saliva was higher in both the groups, compared to normal values but significantly higher in the post-menopause group. There was reduction of mean values for periodontal treatment, but more significant reduction was seen in pre-menopause group. According to Novella et al. 31 Post-menopausal women may have augmented circulating markers like TNF-α , which increases inflammation and increasing artery responsiveness to stimulate vasoconstriction. Studies demonstrated that NSPT reduces inflammation and improves periodontal status.
32
Therefore it can be assumed that overall inflammatory markers also reduce after NSPT. 17~19 Ozmeric et al. 33 has done a comparative study on neopterin levels in saliva, GCF and urine with aggressive periodontitis (AgP) patients, they suggested that mean neopterin levels were higher in saliva and GCF in AgP patients compared to controls. In our study also salivary neopterin levels were increased in both the groups and also decreased levels were seen in both the groups after NSPT, but significant reduction was seen in the pre-menopause group. This study result of reduced neopterin levels after NSPT are consistent with the study by Pradeep et al. 34 . The neopterin levels were correlated with the intensity of disease. The increase in neopterin with periodontal disease progression and decrease after treatment showed that neopterin is involved in the periodontal disease process, as confirmed by the previous study 33 as well as the inflammatory conditions like menopause. Higher neopterin levels in a periodontal patient might reflect the enhanced macrophage infiltration to the periodontal lesion because neopterin is a macrophage activation marker. 35 Macrophage collagenase may have a significant role in collagen destruction in diseased periodontal tissue. Therefore, we should consider changes in neopterin levels as an omen of the host mechanism leading to tissue destruction. infiltration and activation are known to be characteristics of chronic inflammation such as periodontitis. 36 Neopterin is known to take part in nitric oxide syntheses (NOS) production to produce nitric oxide (NO). 37 The presence of NO in saliva is mostly due to the salivary glands which may release NO and it mainly provides the natural antibacterial properties of saliva since it is powerful antimicrobial substance produced in response to periodontopathogens and local inflammatory changes. 36 NO in saliva may be part of the non-specific natural defense mechanism of the oral cavity against pathogenic bacteria. 38 Toniolo et al. 30 stated that menopause is associated with macrophage activation profiles skewed towards pro-inflammatory phenotype.
Macrophages, which play a direct and important function in cell mediated immunity, contain peroxidase, several acid hydrolases and collagenases. 39 to be determined at molecular levels.
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